Exploring the Sermon Drug and Autism

What could an anti-parasitic drug have to do with

one of the biggest autism cover-ups in history?

Let's find out.

Have you heard of the Sermon story?

This might be one of the biggest

medical cover-ups you've never heard of.

Sermon is a drug originally derived from

compounds found in white pine needles.

It's been used for over 100 years

to treat African sleeping sickness due to its powerful anti-parasitic properties.

It works so well that

the World Health Organization supplies it for free in parts of Africa.

But here in the U.S., it isn't approved by the FDA,

and the only way to get it is

through the CDC under strict medical supervision,

essentially making it off-limits to the public.

Now, here's where it gets wild.

In 2017, Dr. Robert Nouveau, out of UC San Diego,

gave a single, low-dose of Sermon to five boys with autism.

Within hours to days, their language improved,

social interaction increased, eye contact returned,

and playfulness and awareness came back.

One child who had never spoke said

his first full sentence.

These kids experienced a complete metabolic reset.

However, Sermon can't be patented.

No one owns it, no one profits from it,

and therefore the study didn't receive any funding.

Dr. Nouveau even went $500,000 in debt to run the study himself,

and the results, well, they were essentially buried.

If you search for it, you'll find fact checks and misinformation because

this is so much bigger than potentially curing autism.

If Sermon works, it supports a massive shift

in everything we've been led to believe.

It would validate something called cell danger response,

a theory that autism isn't purely genetic,

but rather metabolic shutdown triggered by toxins,

infections, or chronic stress.

If this were true, it would shatter the current medical narrative

and expose a multi-billion dollar industry on symptom management.

And maybe that's why you weren't supposed to hear about Sermon.